Advisory Services Network’s Black Diamond Therapeutics BDTX Stock Holding History

Advisory Services Network’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$143	Buy	+67	New	+$159	﹤0.01%	4624
2025 Q4	–	Sell	-67	Closed	-$254	–	2052
2025 Q3	$254	Buy	+67	New	+$196	﹤0.01%	4173
2024 Q1	–	Sell	-100	Closed	-$281	–	1676
2023 Q4	$281	Buy	+100	New	+$235	﹤0.01%	3692
2020 Q4	–	Sell	-150	Closed	-$5K	–	3310
2020 Q3	$5K	Buy	+150	New	+$4.57K	﹤0.01%	2746

Other funds holding BDTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Advisory Services Network's BDTX Position: Q1 2026 in Review

Advisory Services Network opened a new position in Black Diamond Therapeutics (BDTX) in Q1 2026: 67 shares worth $143. The stake represents ﹤0.01% of the portfolio and ranks #4624 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in BDTX as recently as Q3 2025.

Advisory Services Network first reported a position in BDTX in Q3 2020 and has held it in 4 quarters since. The position peaked at $5K in Q3 2020. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

Advisory Services Network held 67 shares of Black Diamond Therapeutics worth $143 as of Q1 2026.
Black Diamond Therapeutics was a new Advisory Services Network position in Q1 2026.
Black Diamond Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4624 holding.
Advisory Services Network first reported a position in Black Diamond Therapeutics in Q3 2020 and has held it in 4 quarters since.
Advisory Services Network's Black Diamond Therapeutics position peaked at $5K in Q3 2020.
104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.